Categories
Articles

ABBS 2008,40(06): Expression and purification of cysteine mutation isoforms of rat lipocalin-type prostaglandin D synthase for nuclear magnetic resonance study

Original Paper

Pdf

file on Synergy OPEN

omments

Acta Biochim Biophys

Sin 2008, 40: 489-496

doi:10.1111/j.1745-7270.2008.00426.x

Expression and purification of cysteine

mutation isoforms of rat lipocalin-type prostaglandin D synthase for nuclear

magnetic resonance study

Jiafu Liu1, Kejiang Lin1, Chenyun

Guo2, Hongchang Gao2, Yihe Yao2, and Donghai Lin1,2*

1

School of Life Science

and Technology, China Pharmaceutical University, Nanjing 210009, China

2

Shanghai Institute of

Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of

Sciences, Shanghai 201203, China

Received: March 3,

2008        Accepted: April 30,

2008

This work was

supported by the grants from the National Natural Science Foundation of China

(30730026 and 30570352)

*Corresponding

author: Tel, 86-21-58433609; Fax, 86-21-50806036; E-mail,

[email protected]

Lipocalin-type prostaglandin (PG) D

synthase (L-PGDS) is the only member of the lipocalin superfamily that displays

enzymatic activity. It binds lipophilic ligands with high affinity and also can

catalyze PGH2 to produce

PGD2. Three cysteine residues, Cys65, Cys89, and Cys186 in L-PGDS, are conserved among all species, of which

Cys89 and Cys186 residues form a disulfide bridge. In this study, we

clarified the effects of thiol groups on the structure of the protein and

investigated the structural significance of Cys residues of rat L-PGDS by

site-directed mutagenesis. Four mutants were constructed by substituting Cys

residues with alanine to identify the correct formation of disulfide bonds among

these three residues. The effects of thiol groups on the structure of rat

L-PGDS were also identified by these mutants. Analysis of HSQC experiments

indicated that these enzymes were all properly folded with well defined

tertiary structures. As the first step towards the 3-D nuclear magnetic

resonance solution structure, we optimized expression of recombinant rat L-PGDS

in Escherichia coli and established an efficient and economic

purification protocol yielding large amounts of pure isotopically labeled rat

L-PGDS. The results of assignments indicated that the wild-type rat L-PGDS

obtained using this expression system was suitable for determination of 3-D

nuclear magnetic resonance solution structure.

Keywords        lipocalin-type prostaglandin D synthase;

mutant; HSQC; heteronuclear NMR

Lipocalin-type prostaglandin (PG) D synthase (L-PGDS) has been known

and studied for many years under another name, b-trace. It is abundantly

expressed in the central nervous system of various mammals, male genitals, and

human heart [1]. In these tissues, L-PGDS catalyzes the isomerization of a

common precursor of various prostanoids, PGH2, to

produce PGD2, an endogenous somnogen [2] and a modulator of pain responses [3],

in the presence of sulfhydryl compounds [4]. L-PGDS is the only enzyme among

members of the lipocalin superfamily [5], which includes a group of

lipid-transporter proteins such as epididymal retinoic acid-binding protein

[6], retinol-binding protein, b-lactoglobulin, major urinary protein, and tear lipocalin [7].

L-PGDS also acts as a lipophilic ligand-binding protein and it binds

biliverdin, bilirubin, retinaldehyde, and retinoic acid with high affinities in

vitro [8]. Thus, this protein is considered to be a dual functional

protein.The xenogenous L-PGDS proteins share a number of common sequences

and structural features. They all belong to N-glycosylated monomeric protein

with 180190 amino acid residues and a molecular mass of 2031 kDa,

depending on the size of the glycosyl moiety [9]. A signal peptide of

approximately 20 amino acid residues is commonly observed at the N-terminus of

L-PGDS and is removed to form the mature enzyme. Cysteine residues Cys89 and Cys186 of L-PGDS form a disulfide bridge that is

highly conserved among most, but not all, lipocalins [5]. The recent study into

the nuclear magnetic resonance (NMR) solution structure of mouse L-PGDS

showed that L-PGDS shares the common structural feature of the lipocalin

superfamily [10], the presence of a six- or eight-stranded b-barrel in their

tertiary structure [11]. Previous studies showed that thiol groups have

important effects on biological and structural characteristics. Furthermore,

proteins often undergo conformational changes to execute their biological

functions, such as an enzyme reaction or ligand binding [12], and structural

stability of the protein is closely related to its biological function [13].

Investigation of structural characteristics of one protein can not only provide

new information concerning the reaction mechanism of the enzyme and ligand

binding, but also help address many questions on the physiological functions

[14]. Thus, it is necessary to clarify the effects of thiol groups on the

structure of the protein that we are investigating.In the present study, we clarified the effects of thiol groups on

the structure of the protein and investigated the structural significance of

Cys residues of rat L-PGDS by site-directed mutagenesis. Four mutants were

constructed by the replacement of cysteine (Cys) with alanine (Ala), namely C186A, C65A, C89,186A, and C65,89,186A mutants. The C65,89,186A mutant was used as a

reference during some experimental processes. These four mutants could help us

to identify the correct disulfide pairing during the expression and

purification processes. Among these isoforms, we selected a suitable protein

for further NMR studies. To further determine the NMR solution structure of rat

L-PGDS, we optimized the expression in Escherichia coli and established

an economic purification protocol yielding sufficient amounts of properly

folded and highly pure isotopically labeled enzyme.

Materials and Methods

Site-directed mutagenesis and plasmid construction

The rat L-PGDS gene in pGEM-T Easy vector, previously

provided by Prof. Yonglian Zhang (Institute of Biochemistry and Cell Biology,

Shanghai Institutes of Biological Science, Chinese Academy of Sciences,

Shanghai, China), was used as a template to clone wild-type protein and

mutants. All of the recombinant proteins lack the 24 amino acid long N-terminal

signal peptide. The GB1-fusion expression vector, pGBTNH, was used in this

study, which was constructed based on the pET-22b vector and GB1 as a partner

protein [15]. The coding sequences of L-PGDS isoforms were amplified by

polymerase chain reaction using appropriate primers, then were inserted into

bacterial expression vector pGBTNH at the cloning sites of BamHI and XhoI.

The successful cloning was confirmed by DNA sequencing. In this study, we

constructed four mutants by the replacement of Cys with Ala, namely C186A, C65A, C89,186A, and C65,89,186A mutants.

Expression and purification of proteins

The expression vectors harboring each enzyme gene were transformed

into E. coli BL21(DE3). Expression and purification of the fusion

proteins were carried out using the following procedures. Ten milliliters of

the overnight culture was added into 1000 ml of LB media and shaken at 37 ?C.

When the OD600 of the culture reached 0.7, 0.25 mM IPTG was added to induce

protein expression with shaking at 37 ?C for 4 h. The cells were harvested by

centrifugation (5000 g, 10 min, 4 ?C), resuspended in buffer A [50 mM

phosphate, 500 mM NaCl (pH 8.0), and 0.5 mM phenylmethylsulphonyl fluoride],

lysed by sonication, and centrifuged (11,000 g, 45 min, 4 ?C). The

supernatant was then loaded onto an Ni-NTA affinity column (Qiagen, Hilden,

Germany) previously equilibrated with buffer A. After the column was washed

using a gradually increasing concentration of imidazole, the GB1-fusion protein

was eluted with 250 mM imidazole in buffer A. The supernatant containing the

GB1-fusion proteins was further purified and desalted by a fast performance

liquid chromatography (FPLC) system equipped with a Superdex 75 10/300 GL

column (GE Healthcare, Wisconsin, USA), previously equilibrated then washed

with buffer B [15 mM phosphate and 150 mM NaCl (pH 6.5)]. Then the GB1-tag was

removed from GB1-fusion protein with bovine thrombin (Sigma, St. Louis, USA)

in buffer B [5 U thrombin/(mg fusion protein), incubation for 12 h at 25 ?C].

After thrombin cleavage, the fractions were loaded onto an Ni-NTA affinity

column and an FPLC system again, as above, to obtain pure samples. The purified

fractions were subjected to sodium dodecyl sulfate-polyacrylamide gel

electrophoresis (SDS-PAGE) (15%) and non-denatured gel electrophoresis followed

by Coomassie staining. The solution samples were stored at room temperature and

the stabilities of proteins were monitored once a week by SDS-PAGE

electrophoresis for 1 month.

Preparation of isotopically labeled samples

Isotopically labeled samples were prepared according to the method

of Marley et al [16]. Uniformly 15N-labeled

samples for 1H

15N HSQC spectra were prepared in

500 ml minimal M9 media containing 2 mM MgSO4, 0.1 mM

CaCl2, 15.1 g/L Na2HPO4·12H2O, 3 g/L KH2PO4, 0.5

g/L NaCl, 3 mg/L FeCl3, 100 mg/ml ampicillin, 2 g/L D-glucose,

and 1 g/L 15NH4Cl (Cambridge Isotope Laboratories, Andover,

USA) as the only source of nitrogen. When the OD600 of

the culture reached 0.40.6 after inoculation of recombinant E. coli BL21, induction

was carried out by adding 0.25 mM IPTG. Cells were harvested after 56 h of

expression and target proteins were purified as described above.

For the preparation of 13C/15N-labeled samples used to record 3-D heteronuclear NMR spectra, 13C-glucose (Cambridge Isotope Laboratories) was used as the only

source of carbon in M9 media. All other steps are similar to those for the

preparation of 15N-labeled samples.

Circular dichroism (CD) spectroscopy

CD spectra were recorded on a J-810 spectropolarimeter (Jasco,

Tokyo, Japan) at room temperature. The protein solutions contained rat L-PGDS

(200 mg/ml) in buffer B. The protein concentration was determined by the

absorption at 280 nm using calculated extinction coefficients. The parameters

for far-ultraviolet (UV) CD measurements were: a cylindrical cell of 0.1 cm

path length; 1 nm bandwidth; 0.1 nm resolution; 0.25 s response time; and a

scan speed of 100 nm/min. Each spectrum was the accumulation of three scans

from 190 to 250 nm followed by noise reduction.CD spectra were recorded on a J-810 spectropolarimeter (Jasco,

Tokyo, Japan) at room temperature. The protein solutions contained rat L-PGDS

(200 mg/ml) in buffer B. The protein concentration was determined by the

absorption at 280 nm using calculated extinction coefficients. The parameters

for far-ultraviolet (UV) CD measurements were: a cylindrical cell of 0.1 cm

path length; 1 nm bandwidth; 0.1 nm resolution; 0.25 s response time; and a

scan speed of 100 nm/min. Each spectrum was the accumulation of three scans

from 190 to 250 nm followed by noise reduction.

Electrospray ionization mass spectrometry (ESI-MS)

Mass spectra of these enzymes were recorded on a Micromass LCT

electrospray time-of-flight mass spectrometer (Waters, Milford, USA) with an

electrospray interface and in positive ion mode. The spray tip potential was

2000 V, the sample cone potential was 50 V, and the desolvation temperature was

150 ?C. As rat L-PGDS and its mutants are highly soluble, we dissolved

lyophilized samples in deionized water at 20 mM. The data were recorded

and processed using Masslynx 3.5 software (Waters).

1H-15N HSQC NMR spectroscopy

Uniformly 15N-labeled samples for NMR spectroscopy were

dissolved in NMR buffer [15 mM sodium phosphate, and 150 mM NaCl (pH 6.5)]

containing 10% D2O, and the protein concentrations were set at

1 mM in 250 ml in a 5 mm microcell NMR tube (Shigemi, Tokyo, Japan). 1H-15N HSQC spectra were measured with a Unity

Inova-600 spectrometer (Varian, Palo Alto, USA) equipped with a triple

resonance probe. Water suppression was achieved by solvent presaturation. The

temperature for NMR experiments was set at 25 ?C. Phase-shifted sine-bell

window functions, solvent-suppression filter on the time-domain data, and

zero-filling were applied before Fourier transformation.

3-D heteronuclear NMR experiments

All of the following NMR experiments were carried out on a Varian

Unity Inova-600 NMR spectrometer. Proteins in NMR buffer were concentrated to 1

mM by a Centricon filter unit (Millipore, Billerica, USA), then 10% D2O was added for the field-lock, and a suite of 3-D heteronuclear NMR

experiments was obtained. The following 3-D triple-resonance experiments were

conducted to obtain sequence-specific assignments for the backbone of rat

L-PGDS: HNCACB, CBCACONH, HNCO, HN(CA)CO, HNCA, HN(CO)CA, CBCA(CO)NH, and

HBHANH. The NMR experiments of C(CO)NH, H(CCO)NH, CCH-TOCSY, HCCH-TOCSY, and 15N-edited TOCSY-HSQC were carried out to obtain side-chain assignment.

The NMR spectra of 13C-edited NOESY-HSQC and 15N-edited NOESY-HSQC were collected to obtain interproton distance

restraints. All spectra were processed by NMRPipe and NMRDraw software [17] and

analyzed using the Sparky 3 program [18]. All software was run on a Linux

system. Linear prediction and zero-filling approaches were used to obtain

complex data matrices of 1024(t3)?256(t1)?128(t2)

before Fourier transformation to improve resolution. The water flip-back

approach was used in HSQC-type experiments to minimize saturation of water

resonance.

Results

Bacterial production of rat L-PGDS protein

Rat L-PGDS and its mutants were expressed in E. coli strain

BL21(DE3). The pGBTNH vector was used to obtain the soluble proteins for NMR

studies. In this system, wild-type enzyme and four mutants were all

produced in soluble state. The C-terminal His-tag allowed purification of the

proteins using chromatography on an Ni-NTA column. After incubation with

thrombin, rat L-PGDS and mutants were further purified by an FPLC system on

Superdex 75 to apparent homogeneity to be more than 95% pure as judged by

SDS-PAGE [Fig. 1(A)]. Under reducing conditions, the wild-type enzyme

and four mutants gave a single band at the same position with a molecular mass

of 19 kDa. The yield of enzymes per liter of bacterial culture varied between

50 mg

and 70 mg, and the yields of C186A and C89,186A mutants were apparently higher than that of C65,89,186A, C65A, and wild-type enzymes. On non-denatured gel

electrophoresis, all enzymes migrated as a homogenous band, suggesting that

they are monomeric proteins [Fig. 1(B)]. They were stable on storage in

a refrigerator for seven weeks or at room temperature for one month. They were

highly soluble and could be concentrated to 30 mg/ml without any visible

precipitation.

Secondary structure analysis

To confirm the proper folding of the bacterially produced rat L-PGDS

and its mutants, the proteins were analyzed by CD spectroscopy. The wavelength

range of CD (190250 nm) is mainly determined by the main-chain conformation and,

therefore, far-UV CD spectra provide information about the secondary structure

of a protein [19]. In this study, the far-UV CD spectra of rat L-PGDS and

mutants showed general similarity (Fig. 2), revealing the typical features

of a predominant b-sheet protein [20] with a negative maximum between 205 and 219 nm

and a positive band below 200 nm. The far-UV CD spectra further showed three

resolved negative peaks at approximately 208, 219, and 222 nm, suggesting that

they all belong to the a+b class of proteins [21]. All enzymes have similar CD spectra

composed of 18% a-helix, 46% b-sheet, and 36% coil, indicating that they have a similar secondary

structure and all fold properly.

Characterization of rat L-PGDS enzymes by ESI-MS

MS was used to further check the purity and identity of these

enzymes. The ESI-MS spectra of wild-type rat L-PGDS and its mutants indicated

that they were all highly pure. The ESI-MS spectra of mutants were similar to

that of wild-type rat L-PGDS. The molecular mass of wild-type rat L-PGDS was

determined to be 20020.1 Da (Fig. 3). This value was in agreement with

the theoretical molecular mass, 20017.4 Da, which is calculated from the amino

acid sequence, including two additional residues (GS) at the N-terminus and

eight residues (LEHHHHHH) at the C-terminus that were included in the expressed

protein for cloning and purification purposes. Molecular masses of C186A, C65A, and C89,186A

mutants were measured to be 19984.2, 19987.2, and 19956.0 Da, respectively

(ESI-MS of these three mutants not shown). Their theoretical molecular masses

were 19985.3, 19985.3 and 19953.3 Da, respectively.

Structural changes monitored by 2-D HSQC experiments

The 2-D 1H-15N HSQC experiment

involving more than one type of nucleus is referred to as a heteronuclear

experiment and is often used in protein studies. It is an 1H-15N correlation experiment that generates cross

peaks resulting from amide proton and amide nitrogen. Each amide group,

including that of side-chains, in amino acid residues (except proline) gives

one single resonance peak in the 2-D 1H-15N HSQC

spectrum. Rat L-PGDS without signal peptide consists of 165 amino acids

including eight prolines that do not contribute signals to the 1H-15N HSQC spectrum. Consequently, together with

the side-chain amide protons, two additional residues (GS) at the N-terminus,

and eight residues (LEHHHHHH) at the C-terminus, approximately 180 cross peaks

would be expected to show in the spectrum. The high dispersion of signals in both

dimensions indicates the proper folding and the well defined tertiary

structures of rat L-PGDS and its mutants (Fig. 4). The effects of disulfide on the protein structure were obtained by

comparing HSQC spectra of proteins with and without disulfide bonds. Overlayed 1H-15N HSQC spectra of rat L-PGDS with disulfide

bonds and C186A mutant without disulfide bonds indicated that they did not adopt

absolutely the same structure [Fig. 4(A)]. However, the relative sites

of two identical amino acids from two isoforms in 1H-15N HSQC spectrum indicated that they adopted a similar conformation;

this was also consistent with the results of CD experiments. Overlayed 1H-15N HSQC spectra of wild-type L-PGDS and C65A mutant indicated that they adopted the same backbone structure [Fig.

4(B)]. This further confirmed that Cys89 and Cys186 residues formed a disulfide bridge. Overlayed 1H-15N HSQC spectra of C89,186A

mutant and C186A mutant, both without disulfide bonds, also indicated that they adopted

the same backbone structure [Fig. 4(C)]. On the basis of small

distinctions on structures of rat L-PGDS and its isoforms, we selected the

wild-type rat L-PGDS, which was closest to the native state, for the

determination of the 3-D solution structure by NMR spectroscopy.

Assignments of wild-type rat L-PGDS

To obtain the 3-D solution structure of proteins and to prepare the

following NMR studies, we first assigned the resonance peaks in NMR spectra using

Sparky software. We usually classify the amino acid spin systems or amino acid

residue types and establish the heteronuclear scalar coupling in triple

resonance experiments such as HNCA, HN(CO)CA, HN(CO)CACB, and HNCACB. Then we

establish sequential connectivities between these spin systems using

through-space coupling in NOESY experiments such as 13C-edited

NOESY-HSQC and 15N-edited NOESY-HSQC [22]. At

the beginning of assignment, the characteristic Ca or Cb chemical shifts of

residues such as Thr/Ser and Gly can help to identify the residue type in the

sequential resonance assignment; proline residues can interrupt the assignment.

However, the residue type identification usually has to be consistent with the

information from 13C-13C or 1H-1H TOCSY-type experiments, or from the pulse

schemes designed for determining the spin topology of specific side-chains and

chemical shifts [23].Nearly complete backbone resonance assignments, including 1HN, 15N, 13CO, 13Ca, 13Cb, and 1Ha, were

achieved for wild-type rat L-PGDS (Fig. 5). The side-chain resonances

were approximately 75% complete. The results of assignments indicated that the

wild-type rat L-PGDS obtained using this expression system was suitable for

determination of 3-D NMR solution structure.

Discussion

In this study, we developed an E. coli system expressing a

rat L-PGDS and its mutants with GB1 as the fusion protein. This system yielded

highly soluble and stable fusion proteins, as the fusion partner is very small

and highly soluble to help target proteins fold correctly. The wild-type rat

L-PGDS and four mutants all obtained high yield expression and folded correctly

in this study. The single bands of these enzymes on non-denatured gel

electrophoresis indicated that they were pure and monomeric proteins. The

results of ESI-MS also indicated that there was no formation of intermolecular

disulfide bonds. On non-denatured gel electrophoresis, wild-type enzyme and C65A mutant migrated in the gel faster than other enzyme mutants [Fig.

1(B)], suggesting that Cys89 and Cys186 residues constructed an intramolecular disulfide linkage. The rat

L-PGDS mutants without intramolecular disulfide linkage might become less

compacted during non-denatured gel electrophoresis, and migrate slowly.

However, if Cys65 and Cys186

residues form a disulfide bond, the wild-type rat L-PGDS would display two

states on non-denatured gel electrophoresis. These results further indicated

that the correct disulfide pairing could be formed using this expression

system, which is necessary for structural study. The Cys186 residue in a flexible C-terminal loop of the enzyme could only form

the disulfide linkage with the Cys89 residue, not with Cys65, and the Cys65 and Cys89 residues did not form the disulfide bond. These results suggested that

Cys89 and Cys186 might be exposed on the surface of rat

L-PGDS molecules to a greater extent than Cys65. This

is in agreement with the structure of mouse L-PGDS [10] and the homology

modeling structure, in which the Cys65 residue exists in the

hydrophobic pocket of the enzyme and an intramolecular disulfide bridge between

Cys89 and Cys186 occurs outside the barrel structure.

However, the enzyme activity of L-PGDS decreased concomitantly with the loss of

the free thiol group of Cys65 and the replacement of Cys65 with Ser/Ala by site-directed mutagenesis led to complete loss of

catalytic activity. The absence of the disulfide bond in rat L-PGDS might allow

a broader range of ligands to fit into the barrel pocket and slightly increases

the affinity of rat L-PGDS for ligands (data not shown).To examine the proper folding of the bacterially produced enzymes

and the effects of removing the disulfide bond on their structures, the

proteins were analyzed by CD spectroscopy. The similarities among CD spectra

recorded on these enzymes indicated that they adopted similar secondary

structures and there were non-significant effects on their conformations after

removing the disulfide bond. The CD spectra recorded on rat L-PGDS proteins

described in this work, compared with those published in previous reports for

native or recombinant proteins, indicated the correct folding of all rat L-PGDS

enzymes prepared according to our strategy, even though these enzymes lack

their natural glycosylation due to their expression in a prokaryotic host. The

secondary structure contents of rat L-PGDS enzymes were similar to those of b-lactoglobulin,

a member of the lipocalin family, estimated from both CD spectra and X-ray

crystallography [24]. There were no significant effects on their secondary

structures after removing the disulfide bond due to correct disulfide pairing,

proper folding, and no forming of intermolecular disulfide linkage.Two-dimensional 1H-15N HSQC

spectrum is a reliable method to judge the suitability of a particular protein

for structural determination with NMR spectroscopy. A well-folded protein would

display a wide dispersion of amide proton chemical shifts in 2-D 1H-15N HSQC spectrum [25]. In this study, the

proper folding of rat L-PGDS and its mutants was examined by 1H-15N HSQC spectrum. The high dispersion of 180

cross peaks in the spectrum was indicative of correct folding and well defined

tertiary structures of rat L-PGDS or its mutants. The effects of disulfide on

protein conformation could be elucidated by overlapping the 1H-15N HSQC spectra of rat L-PGDS and its mutants.

By comparing these spectra, we found that the enzymes with disulfide bonds

adopted almost the same conformations, and the enzymes without disulfide bonds

also adopted similar conformations. However, conformations without disulfide

bonds became less compact. The results of HSQC experiments further confirmed

that the correct disulfide bond was formed and there were no significant

effects on their structures after removing the disulfide bond. Thus, we

selected the wild-type rat L-PGDS, which is closest to the native state, for

the determination of the 3-D solution structure by NMR spectroscopy.Using this expression system, we yielded highly soluble, pure, and

stable proteins of rat L-PGDS and its mutants. However, there are three Cys

residues in wild-type rat L-PGDS. We were compelled to identify if these Cys

residues could form the correct disulfide bond before carrying out the

following studies. The results of non-denatured gel electrophoresis indicated

that Cys89 and Cys186 residues could construct disulfide bonds

correctly, but Cys65 did not contribute to the formation of

disulfide bonds. The ESI-MS results further identified that there were no

intermolecular disulfide bonds in rat L-PGDS and its mutants. The results of CD

and 2-D 1H-15N HSQC experiments indicated that there were

no significant effects on their structures after removal of the disulfide bond.

In conclusion, the expression and purification protocol designed for wild-type

rat L-PGDS is suitable and economic to yield enough properly folded and

monomeric protein with correct disulfide pairing to allow determination of 3-D

solution structure by NMR spectroscopy.

References

 1   Inui T, Ohkubo T, Urade

Y, Hayaishi O. Enhancement of lipocalin-type prostaglandin D synthase enzyme

activity by guanidine hydrochloride. Biochem Biophys Res Commun 1999, 266: 641646

 2   Qu WM, Huang ZL, Xu XH,

Aritake K, Eguchi N, Nambu F, Narumiya S et al. Lipocalin-type

prostaglandin D synthase produces prostaglandin D2 involved in

regulation of physiological sleep. Proc Natl Acad Sci USA 2006, 103:

1794917954

 3   Eguchi N, Minami T,

Shirafuji N, Kanaoka Y, Tanaka T, Nagata A, Yoshida N et al. Lack of

tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient

mice. Proc Natl Acad Sci USA 1999, 96: 726730

 4   Urade Y, Tanaka T, Eguchi

N, Kikuchi M, Kimura H, Toh H, Hayaishi O. Structural and functional

significance of cysteine residues of glutathione-independent prostaglandin D

synthase. Identification of Cys65 as an essential thiol. J Biol

Chem 1995, 270: 14221428

 5   Toh H, Kubodera H,

Nakajima N, Sekiya T, Eguchi N, Tanaka T, Urade Y et al.

Glutathione-independent prostaglandin D synthase as a lead molecule for

designing new functional proteins. Protein Eng 1996, 9: 10671082

 6   Pattanayek R, Newcomer

ME. Protein and ligand adaptation in a retinoic acid binding protein. Protein

Sci 1999, 8: 20272032

 7   Breustedt DA, Kornd?rfer

IP, Redl B, Skerra A. The 1.8-? crystal structure of human tear lipocalin

reveals an extended branched cavity with capacity for multiple ligands. J Biol

Chem 2005, 280: 484493

 8   Beuckmann CT, Aoyagi M,

Okazaki I, Hiroike T, Toh H, Hayaishi O, Urade Y. Binding of biliverdin,

bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase.

Biochemistry 1999, 38: 80068013

 9   Urade Y, Hayaishi O.

Biochemical, structural, genetic, physiological, and pathophysiological

features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta 2000,

1482: 259271

10  Shimamoto S, Yoshida T, Inui T,

Gohda K, Kobayashi Y, Fujimori K, Tsurumura T et al. NMR solution

structure of lipocalin-type prostaglandin D synthase: evidence for partial

overlapping of catalytic pocket and retinoic acid-binding pocket within the

central cavity. J Biol Chem 2007, 282: 3137331379

11  Grzyb J, Latowski D, Strzalka

K. Lipocalins ––– a family portrait. J Plant Physiol 2006, 163: 895915

12  Kay LE. Protein dynamics from

NMR. Nat Struct Biol 1998, 5: 513517

13  Frauenfelder H, Sligar SG,

Wolynes PG. The energy landscapes and motions of proteins. Science 1991, 254:

15981603

14  Berkner H, Engelhorn J,

Liscombe DK, Schweimer K, W?hrl BM, Facchini PJ, R?sch P et al.

High-yield expression and purification of isotopically labeled norcoclaurine

synthase, a Bet v 1-homologous enzyme, from Thalictrum flavum for NMR

studies. Protein Expr Purif 2007, 56: 197204

15  Bao WJ, Gao YG, Chang YG, Zhang

TY, Lin XJ, Yan XZ, Hu HY. Highly efficient expression and purification system

of small-size protein domains in Escherichia coli for biochemical

characterization. Protein Expr Purif 2006, 47: 599606

16  Marley J, Lu M, Bracken C. A

method for efficient isotopic labeling of recombinant proteins. J Biomol

NMR 2001, 20: 7175

17  Delaglio F, Grzesiek S, Vuister

GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing

system based on UNIX pipes. J Biomol NMR 1995, 6: 277293

18  Goddard TD, Kneller DG. Sparky

3 (Computer program). San Francisco: University of California 2006

19  Breustedt DA, Sch?nfeld DL,

Skerra A. Comparative ligand-binding analysis of ten human lipocalins. Biochim

Biophys Acta 2006, 1764: 161173

20  Brahms S, Brahms J.

Determination of protein secondary structure in solution by vacuum ultraviolet

circular dichroism. J Mol Biol 1980, 138: 149178

21 Nallamsetty S, Dubey VK, Pande

M, Ambasht PK, Jagannadham MV. Accumulation of partly folded states in the

equilibrium unfolding of ervatamin A: spectroscopic description of the native, intermediate,

and unfolded states. Biochimie 2007, 89: 14161424

22  Clore GM, Gronenborn AM.

Multidimensional heteronuclear nuclear magnetic resonance of proteins. Methods

Enzymol 1994, 239: 349363

23  Iwai H, Fiaux J. Use of

biosynthetic fractional 13C-labeling for backbone NMR

assignment of proteins. J Biomol NMR 2007, 37: 187193

24  Kuwajima K, Yamaya H, Sugai S.

The burst-phase intermediate in the refolding of b-lactoglobulin

studied by stopped-flow circular dichroism and absorption spectroscopy. J Mol Biol

1996, 264: 806822

25  Liu DJ, Cocco M, Matsumura M,

Ren D, Becker B, Richard L, Remmele Jr et al. Assignment of 1H, 13C and 15N resonances of the

reduced human IgG1 CH3 domain. Biomol NMR Assign 2007, 1: 93–94